Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02327845 · ClinicalTrials.gov registry record
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
A clinical trial, sponsored by University of Miami.
- Active
- Registry status
- 708
- Enrollment target
NCT02327845 is a clinical trial that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 708 participants.
The verdict
NCT02327845 is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- 708 participants
- Enrollment target
Study Summary
The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotemporal dementia (FTD); and (2) to develop biomarkers that might be useful in aiding therapy development for this group of disorders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 708 participants |
| Start Date | 2015-04 |
| Est. Completion | 2031-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02327845
The ClinicalTrials.gov registry entry for NCT02327845 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 708 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02327845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02327845 about?
NCT02327845 is a clinical study titled "Phenotype, Genotype & Biomarkers in ALS and Related Disorders". The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotempora...
What is the current status of trial NCT02327845?
This trial is currently active not recruiting. The enrollment target is 708 participants. The study started on 2015-04. Estimated completion is 2031-08.
Who is sponsoring clinical trial NCT02327845?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.